Cooper Companies Inc (COO): Allan E Rubenstein , director of Cooper Companies Inc sold 3,000 shares on Jun 6, 2016. The Insider selling transaction was reported by the company on Jun 7, 2016 to the Securities and Exchange Commission. The shares were sold at $165.01 per share for a total value of $495,019.81 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 7, 2016, Carol R Kaufman (EVP, Sec. & Chief Gov. Officer) sold 49,500 shares at $163.85 per share price.On Mar 10, 2016, Gregory W Matz (SVP, CFO & CRO) sold 10,000 shares at $146.94 per share price.Also, On Oct 6, 2015, Allan E Rubenstein (director) sold 294 shares at $150.00 per share price.On Sep 8, 2015, Steven Rosenberg (director) sold 17,500 shares at $149.44 per share price.
Shares of Cooper Companies Inc (COO) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -2.02 points or -1.21% at $165.4 with 13,76,342 shares getting traded. Post opening the session at $171.05, the shares hit an intraday low of $164.01 and an intraday high of $173.5 and the price vacillated in this range throughout the day. The company has a market cap of $8,004 M and the number of outstanding shares has been calculated to be 4,83,91,028 shares. The 52-week high of Cooper Companies Inc is $186.37 and the 52-week low is $119.28.
Company has been under the radar of several Street Analysts.Cooper Companies Inc is Reiterated by Jefferies to Buy and the brokerage firm has raised the Price Target to $ 190 from a previous price target of $175 .The Rating was issued on Jun 3, 2016.Cooper Companies Inc is Upgraded by Jefferies to Buy. Earlier the firm had a rating of Hold on the company shares. The Rating was issued on Apr 15, 2016.
The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch SeeClear and Mobius.